Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LBRX compared with ALT: revenue, margins and what each company keeps, and the suppliers and customers both name
LBRX
LB Pharmaceuticals Inc
Change
Mkt cap
Revenue
Revenue
ALT
Altimmune, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LBRX
LB Pharmaceuticals Inc
vs
ALT
Altimmune, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
LBRX: latest quarter not drawable. ALT: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
No disclosed counterparties: LBRX, ALT.
Role chip = supplier or customer
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LBRX, solid
ALT, dashed
LBRX
LB Pharmaceuticals Inc
Change
39.74
▼
−1.02%
· post 41.20
Mkt cap
$1.2B
Revenue
—
Revenue
—
ALT
Altimmune, Inc.
Change
2.04
▼
−4.90%
· post 2.07
Closed
Oct 30 '26
Mkt cap
$396.8M
Revenue
$26,000
Q4 FY25
Revenue
$41,000
FY25
vs
Compare
Closed
Oct 30 '26
LBRX
LB Pharmaceuticals Inc
vs
ALT
Altimmune, Inc.
39.74
▼
−1.02%
post 41.20
Price
2.04
▼
−4.90%
post 2.07
$1.2B
Mkt cap
$396.8M
—
Revenue
$26,000
Q4 FY25
—
Revenue
$41,000
FY25
Change
Change
LBRX
39.74
▼
−1.02%
vs
ALT
2.04
▼
−4.90%
Closed
Oct 30 '26